Post Pandemic Cardiac Prediction: Analysing Heart Attack Mortality Rate In Vaccinated Adults

Year : 2024 | Volume :14 | Issue : 02 | Page : –
By

Sushiladevi Vantamuri

  1. Project Guide S. G. Balekundri Institute of Technology Belagavi India

Abstract

Heart disease has emerged as a prominent contributor to global mortality rates. Discovered it early and providing timely management can significantly reduce the incidence of heart failures, death rates, and diagnostic costs associated with heart disease. In this study, we propose employing notification system to assess the risk of heart disease and explore potential associations between vaccination status and mortality rates due to heart attack among adult populations in the aftermath of the pandemic. This study employs statistical analysis and utilizes the data from vaccinated individuals to investigate potential correlations between COVID-19 vaccination and incidence of heart attacks , thereby contributing to our understanding of the deep health impacts of vaccination efforts. Through a machine learning forthcoming, we aim to analyse post-pandemic cardiac prediction by inspecting heart attack mortality rates among vaccinated adults.

Keywords: Clinical Data,Heart Disease, Vaccination, Algorithm, Dataset, Artificial Intelligence.,Machine learning.

[This article belongs to Research & Reviews: A Journal of Health Professions(rrjohp)]

How to cite this article: Sushiladevi Vantamuri. Post Pandemic Cardiac Prediction: Analysing Heart Attack Mortality Rate In Vaccinated Adults. Research & Reviews: A Journal of Health Professions. 2024; 14(02):-.
How to cite this URL: Sushiladevi Vantamuri. Post Pandemic Cardiac Prediction: Analysing Heart Attack Mortality Rate In Vaccinated Adults. Research & Reviews: A Journal of Health Professions. 2024; 14(02):-. Available from: https://journals.stmjournals.com/rrjohp/article=2024/view=149764

References

  1. Levin, ‘‘The clinical epidemiology of cardiovascular diseases in chronic kidney disease: Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis,’’ Mar. 2022.
  2. S. Reddy, ‘‘Cardiovascular diseases in the developing countries: Dimensions, determinants, dynamics and directions for public health action,’’ Feb. 2022.
  3. Kishore, A. Kumar, K. Singh, M. Punia, and Y. Hambir, ‘‘Heart attack prediction using deep learning,’’ 2021.
  4. D. Mathers and D. Loncar, ‘‘Projections of global mortality and burden of disease from 2002 to 2030,’’ Nov. 2020.
  5. Aden D, Zaheer S, Kumar R, Raj S, Khan T, Varshney S. Beyond COVID-19 and SARS-CoV-2, cardiovascular outcomes of “long covid” from a pathological perspective–a look back and road ahead. Pathology-Research and Practice. 2022 Nov 1;239:154144.
  6. Azzalini E., D’Errico S., et al. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality. Life Sci. 2022.  [7] Núñez-Gil I.J., Fernández-Ortiz A., Maroud Eid C., Huang J., Romero R., Becerra-Muñoz V.M., Uribarri A., Feltes G., Trabatoni D., Fernandez-Rozas I., et al. Underlying heart diseases and acute COVID-19 outcomes. Cardiol. J. 2021.
  7. Henning RJ. Cardiovascular complications of COVID-19 severe acute respiratory syndrome. American Journal of Cardiovascular Disease. 2022;12(4):170.
  8. Al-Ali D., Elshafeey A., Mushannen M., Kawas H., Shafiq A., Mhaimeed N., Mhaimeed O., Mhaimeed N., Zeghlache R., Salameh M., et al. Cardiovascular and haematological events post COVID-19 vaccination: A systematic review. J. Cell. Mol. Med. 2021.
  9. Núñez-Gil IJ, Olier I, Feltes G, Viana-Llamas MC, Maroun-Eid C, Romero R, Fernández-Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, García-Aguado M. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. American Heart Journal. 2021 Jul 1;237:104-15.
  10. El-Battrawy I., Nuñez-Gil I.J., Abumayyaleh M., Estrada V., Manuel BecerraMuñoz V., Uribarri A., Fernández-Rozas I., Feltes G., Arroyo-Espliguero R., Trabattoni D., et al. COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain- Germany) Eur. J. Clin. Investig. 2021.
  11. Santoro F., Nuñez-Gil I.J., Vitale E., VianaLlamas M.C., Reche-Martinez B., RomeroPareja R., Feltez Guzman G., Fernandez Rozas I., Uribarri A., Becerra-Muñoz V.M., et al. Antiplatelet therapy and outcome in COVID-19: The Health Outcome Predictive Evaluation
  12. Heart. 2022. Clemente-Moragón A., Martínez-Milla J., Oliver E., Santos A., Flandes J., Fernández I., Rodríguez-González L.,Serrano Del Castillo C., Ioan A.M., LópezÁlvarez M., et al. Metoprolol in Critically Ill Patients with COVID-19. J. Am. Coll. Cardiol. 2021
  13. Gerretsen P., Kim J., Caravaggio F., Quilty L., Sanches M., Wells S., Brown E.E., Agic B., Pollock B.G., Graff-Guerrero A. Individual determinants of COVID-19 vaccine hesitancy. PLoS ONE. 2021.
  14. Salah H.M., Mehta J.L. COVID-19 Vaccine and Myocarditis. Am. J. Cardiol. 2021
  15. Gundry S.R. Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation. 2021
  16. Fernández-de-Las-Peñas C., Pellicer-Valero O.J., Navarro-Pardo E., Palacios-Ceña D., Florencio L.L., Guijarro C., Martín-Guerrero J.D. Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Longterm Post-COVID Symptoms.

 

Regular Issue Subscription Review Article
Volume 14
Issue 02
Received May 1, 2024
Accepted June 5, 2024
Published June 12, 2024
Views: 28